274 related articles for article (PubMed ID: 20634175)
1. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
[TBL] [Abstract][Full Text] [Related]
2. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
Bays HE
Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
[TBL] [Abstract][Full Text] [Related]
3. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
[TBL] [Abstract][Full Text] [Related]
4. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
Bays HE; Goldberg RB; Truitt KE; Jones MR
Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
[TBL] [Abstract][Full Text] [Related]
5. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
J Clin Lipidol; 2012; 6(4):318-24. PubMed ID: 22836068
[TBL] [Abstract][Full Text] [Related]
6. Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes.
Rosenstock J; Hernandez-Triana E; Handelsman Y; Misir S; Jones MR; Nagendran S
Postgrad Med; 2012 Jul; 124(4):7-13. PubMed ID: 22913889
[TBL] [Abstract][Full Text] [Related]
7. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
Fonseca VA; Rosenstock J; Wang AC; Truitt KE; Jones MR
Diabetes Care; 2008 Aug; 31(8):1479-84. PubMed ID: 18458145
[TBL] [Abstract][Full Text] [Related]
8. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
[TBL] [Abstract][Full Text] [Related]
9. Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.
Rigby SP; Handelsman Y; Lai YL; Abby SL; Tao B; Jones MR
Endocr Pract; 2010; 16(1):53-63. PubMed ID: 19789153
[TBL] [Abstract][Full Text] [Related]
10. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Jialal I; Abby SL; Misir S; Nagendran S
Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Gavin JR; Jones MR; Ford DM; Truitt KE
Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
[TBL] [Abstract][Full Text] [Related]
12. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
Rosenson RS; Abby SL; Jones MR
Atherosclerosis; 2009 Jun; 204(2):342-4. PubMed ID: 18996525
[TBL] [Abstract][Full Text] [Related]
13. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.
Rosenstock J; Rigby SP; Ford DM; Tao B; Chou HS
Horm Metab Res; 2014 May; 46(5):348-53. PubMed ID: 24356792
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.
Rosenstock J; Hernandez-Triana E; Handelsman Y; Misir S; Jones MR
Postgrad Med; 2012 Jul; 124(4):14-20. PubMed ID: 22913890
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of colesevelam in combination with pioglitazone in patients with type 2 diabetes mellitus.
Rosenstock J; Truitt KE; Baz-Hecht M; Ford DM; Tao B; Chou HS
Horm Metab Res; 2014 Dec; 46(13):943-9. PubMed ID: 25054436
[TBL] [Abstract][Full Text] [Related]
17. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Simons WR; Hagan MA
Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
[TBL] [Abstract][Full Text] [Related]
19. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
Marrs JC
Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
[TBL] [Abstract][Full Text] [Related]
20. Diurnal glucose profiles using continuous glucose monitoring to identify the glucose-lowering characteristics of colesevelam HCl (Welchol).
Mazze RS; Strock ES; Monk AM; Murphy MM; Xi M; Bergenstal RM
Endocr Pract; 2013; 19(2):275-83. PubMed ID: 23598534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
